165 related articles for article (PubMed ID: 14675158)
1. Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Delta8-tetrahydrocannabinol.
Yamaguchi T; Kubota T; Watanabe S; Yamamoto T
J Neurochem; 2004 Jan; 88(1):148-54. PubMed ID: 14675158
[TBL] [Abstract][Full Text] [Related]
2. Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats.
Yamaguchi T; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2001 Jan; 889(1-2):149-54. PubMed ID: 11166698
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibition and prostaglandin receptors in experimental nephritis.
Waldner C; Heise G; Schrör K; Heering P
Eur J Clin Invest; 2003 Nov; 33(11):969-75. PubMed ID: 14636300
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
5. A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing.
Carriero D; Aberman J; Lin SY; Hill A; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 1998 May; 137(2):147-56. PubMed ID: 9630001
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cyclooxygenase-2 and EP3 prostaglandin receptor in acute herpetic but not postherpetic pain in mice.
Takasaki I; Nojima H; Shiraki K; Sugimoto Y; Ichikawa A; Ushikubi F; Narumiya S; Kuraishi Y
Neuropharmacology; 2005 Sep; 49(3):283-92. PubMed ID: 15925391
[TBL] [Abstract][Full Text] [Related]
8. Key role for cyclooxygenase-2 in PGE2 and PGF2alpha receptor regulation and cerebral blood flow of the newborn.
Li DY; Hardy P; Abran D; Martinez-Bermudez AK; Guerguerian AM; Bhattacharya M; Almazan G; Menezes R; Peri KG; Varma DR; Chemtob S
Am J Physiol; 1997 Oct; 273(4):R1283-90. PubMed ID: 9362291
[TBL] [Abstract][Full Text] [Related]
9. PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period.
Dumont I; Peri KG; Hardy P; Hou X; Martinez-Bermudez AK; Molotchnikoff S; Varma DR; Chemtob S
Am J Physiol; 1998 Dec; 275(6):R1812-21. PubMed ID: 9843870
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery.
Kobayashi K; Murata T; Hori M; Ozaki H
Eur J Pharmacol; 2011 Jun; 660(2-3):375-80. PubMed ID: 21463619
[TBL] [Abstract][Full Text] [Related]
11. Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum.
Slawik H; Volk B; Fiebich B; Hüll M
Neurochem Int; 2004 Oct; 45(5):653-60. PubMed ID: 15234107
[TBL] [Abstract][Full Text] [Related]
12. Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition.
Hardy P; Bhattacharya M; Abran D; Peri KG; Asselin P; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1888-98. PubMed ID: 9727412
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.
Anggadiredja K; Nakamichi M; Hiranita T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
Neuropsychopharmacology; 2004 Aug; 29(8):1470-8. PubMed ID: 15085091
[TBL] [Abstract][Full Text] [Related]
14. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
16. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol.
Economidou D; Mattioli L; Ubaldi M; Lourdusamy A; Soverchia L; Hardiman G; Campolongo P; Cuomo V; Ciccocioppo R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):73-85. PubMed ID: 17618662
[TBL] [Abstract][Full Text] [Related]
17. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
Arosh JA; Banu SK; Chapdelaine P; Fortier MA
Endocrinology; 2004 Jan; 145(1):407-17. PubMed ID: 14500566
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the relaxation response induced by bradykinin in the epithelium-intact guinea-pig trachea in vitro.
Schlemper V; Medeiros R; Ferreira J; Campos MM; Calixto JB
Br J Pharmacol; 2005 Jul; 145(6):740-50. PubMed ID: 15852038
[TBL] [Abstract][Full Text] [Related]
19. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts.
Choung J; Taylor L; Thomas K; Zhou X; Kagan H; Yang X; Polgar P
J Cell Biochem; 1998 Nov; 71(2):254-63. PubMed ID: 9779823
[TBL] [Abstract][Full Text] [Related]
20. Decrease in prostaglandin level is a prerequisite for the expression of cannabinoid withdrawal: a quasi abstinence approach.
Anggadiredja K; Yamaguchi T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2005 Dec; 1066(1-2):201-5. PubMed ID: 16336946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
